Neurologic Disorders Therapeutics

A Global Strategic Business Report

MCP26617


EXECUTIVE INSIGHTS
DOMAIN EXPERTS
PLAYERS
PARTICIPANTS
  • FEB 2025
  • EDITION 2
  • TABLES 210
  • REGIONS 26
  • SEGMENTS 7
  • PAGES 289
  • US$ 5600
  • MCP26617
  • JOIN OUR PANEL

EXECUTIVE ENGAGEMENTS BY TIER

  • CXO

  • VICE PRESIDENT

  • DIRECTOR

  • MANAGER

  • MARKETING

REQUEST FULL-STACK INDEX

Includes 350+ pages validated sources

QUESTIONNAIRE EXECUTIVES DATA ROOM
  

HIGHLIGHTS & REPORT INDEX

Global Neurologic Disorders Therapeutics Market to Reach US$149.7 Billion by 2030

The global market for Neurologic Disorders Therapeutics estimated at US$121.2 Billion in the year 2024, is expected to reach US$149.7 Billion by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Anticholinergic Drug Class, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$45.2 Billion by the end of the analysis period. Growth in the Analgesics Drug Class segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$32.7 Billion While China is Forecast to Grow at 6.9% CAGR

The Neurologic Disorders Therapeutics market in the U.S. is estimated at US$32.7 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$31.3 Billion by the year 2030 trailing a CAGR of 6.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.1% and 2.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Global Neurologic Disorders Therapeutics Market - Key Drivers and Trends Summarized

Neurologic disorders encompass a broad range of conditions that affect the nervous system, including the brain, spinal cord, and peripheral nerves. These disorders can be debilitating and include diseases such as Alzheimer`s, Parkinson`s, multiple sclerosis, epilepsy, and stroke, among others. The therapeutic approaches for neurologic disorders vary widely depending on the specific condition, but generally aim to manage symptoms, slow disease progression, and improve the quality of life for patients. Treatments can include medications, physical and occupational therapy, lifestyle changes, and, in some cases, surgical interventions.

The field of neurologic disorder therapeutics has seen significant advancements over the past few decades. The development of disease-modifying therapies has transformed the management of conditions like multiple sclerosis and Parkinson`s disease, offering patients options that go beyond symptomatic relief. For instance, the introduction of monoclonal antibodies and other biologic drugs has provided new avenues for targeting the underlying pathophysiology of these diseases. Advances in neuroimaging and biomarker research have also enhanced early diagnosis and personalized treatment plans. Moreover, innovative drug delivery systems, such as intrathecal pumps and transdermal patches, have improved the efficacy and convenience of administering neurologic medications.

The growth in the neurologic disorders therapeutics market is driven by several factors. Firstly, the increasing prevalence of neurologic conditions, particularly among aging populations, has heightened the demand for effective treatments. Secondly, advancements in biotechnology and pharmaceutical research are continuously leading to the development of new and improved therapies, including gene therapies and neuroprotective agents. The expansion of healthcare infrastructure in emerging markets has also facilitated better access to neurologic care, contributing to market growth. Additionally, strategic collaborations between pharmaceutical companies, academic institutions, and research organizations are accelerating the discovery and commercialization of innovative treatments. The rise of digital health technologies, including telemedicine and wearable devices, is enhancing patient monitoring and management, leading to better outcomes. Lastly, increased funding for neurologic research and the development of comprehensive treatment guidelines are fostering a more structured and effective approach to managing neurologic disorders.

 

SCOPE OF STUDY

The report analyzes the Neurologic Disorders Therapeutics market by the following Segments, and Geographic Regions/Countries:

Segments:
Drug Class (Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class, Other Drug Classes); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies).

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa..

SELECT PLAYERS

AstraZeneca PLC; Biogen, Inc.; Biohaven, Ltd.; Eisai Co., Ltd.; H. Lundbeck A/S; Ionis Pharmaceuticals, Inc.; Mitsubishi Tanabe Pharma Corporation; Neurelis, Inc.; Neurocrine Biosciences, Inc.; Neurona Therapeutics, Inc.; Ovid Therapeutics, Inc.; Pfizer, Inc.; Sanofi SA; UCB SA; Voyager Therapeutics, Inc.

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Economic Update
Neurologic Disorders Therapeutics – Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for 86 Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Prevalence of Neurologic Disorders Drives Demand for Therapeutics
Advancements in Neurotherapeutics Propel Market Growth
Growing Awareness of Neurologic Health Expands Addressable Market Opportunity
Development of Precision Medicine and Targeted Therapies Strengthens Business Case
Innovations in Neurostimulation and Neuromodulation Therapies Generate Market Interest
Development of Regenerative Medicine and Stem Cell Therapies Propels Market Growth
4. GLOBAL MARKET PERSPECTIVE
World Neurologic Disorders Therapeutics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
World Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
World Historic Review for Neurologic Disorders Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
World 15-Year Perspective for Neurologic Disorders Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
World Recent Past, Current & Future Analysis for Anticholinergic Drug Class by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
World Historic Review for Anticholinergic Drug Class by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
World 15-Year Perspective for Anticholinergic Drug Class by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
World Recent Past, Current & Future Analysis for Analgesics Drug Class by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
World Historic Review for Analgesics Drug Class by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
World 15-Year Perspective for Analgesics Drug Class by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
World Recent Past, Current & Future Analysis for Antiepileptic Drug Class by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
World Historic Review for Antiepileptic Drug Class by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
World 15-Year Perspective for Antiepileptic Drug Class by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
World Recent Past, Current & Future Analysis for Other Drug Classes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
World Historic Review for Other Drug Classes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
World 15-Year Perspective for Other Drug Classes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
World 15-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
World 15-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
World Historic Review for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
World 15-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
UNITED STATES
Neurologic Disorders Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
USA Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
USA Historic Review for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
USA 15-Year Perspective for Neurologic Disorders Therapeutics by Drug Class - Percentage Breakdown of Value Sales for Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes for the Years 2015, 2025 & 2030
USA Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
USA Historic Review for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
USA 15-Year Perspective for Neurologic Disorders Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
CANADA
Canada Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Canada Historic Review for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Canada 15-Year Perspective for Neurologic Disorders Therapeutics by Drug Class - Percentage Breakdown of Value Sales for Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes for the Years 2015, 2025 & 2030
Canada Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Canada Historic Review for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Canada 15-Year Perspective for Neurologic Disorders Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
JAPAN
Neurologic Disorders Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
Japan Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Japan Historic Review for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Japan 15-Year Perspective for Neurologic Disorders Therapeutics by Drug Class - Percentage Breakdown of Value Sales for Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes for the Years 2015, 2025 & 2030
Japan Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Japan Historic Review for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Japan 15-Year Perspective for Neurologic Disorders Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
CHINA
Neurologic Disorders Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
China Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
China Historic Review for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
China 15-Year Perspective for Neurologic Disorders Therapeutics by Drug Class - Percentage Breakdown of Value Sales for Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes for the Years 2015, 2025 & 2030
China Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
China Historic Review for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
China 15-Year Perspective for Neurologic Disorders Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
EUROPE
Neurologic Disorders Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
Europe Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
Europe Historic Review for Neurologic Disorders Therapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Europe 15-Year Perspective for Neurologic Disorders Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
Europe Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Europe Historic Review for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Europe 15-Year Perspective for Neurologic Disorders Therapeutics by Drug Class - Percentage Breakdown of Value Sales for Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes for the Years 2015, 2025 & 2030
Europe Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Europe Historic Review for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Europe 15-Year Perspective for Neurologic Disorders Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
FRANCE
Neurologic Disorders Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
France Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
France Historic Review for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
France 15-Year Perspective for Neurologic Disorders Therapeutics by Drug Class - Percentage Breakdown of Value Sales for Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes for the Years 2015, 2025 & 2030
France Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
France Historic Review for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
France 15-Year Perspective for Neurologic Disorders Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
GERMANY
Neurologic Disorders Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
Germany Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Germany Historic Review for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Germany 15-Year Perspective for Neurologic Disorders Therapeutics by Drug Class - Percentage Breakdown of Value Sales for Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes for the Years 2015, 2025 & 2030
Germany Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Germany Historic Review for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Germany 15-Year Perspective for Neurologic Disorders Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
ITALY
Italy Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Italy Historic Review for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Italy 15-Year Perspective for Neurologic Disorders Therapeutics by Drug Class - Percentage Breakdown of Value Sales for Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes for the Years 2015, 2025 & 2030
Italy Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Italy Historic Review for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Italy 15-Year Perspective for Neurologic Disorders Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
UNITED KINGDOM
Neurologic Disorders Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
UK Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
UK Historic Review for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
UK 15-Year Perspective for Neurologic Disorders Therapeutics by Drug Class - Percentage Breakdown of Value Sales for Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes for the Years 2015, 2025 & 2030
UK Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
UK Historic Review for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
UK 15-Year Perspective for Neurologic Disorders Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
SPAIN
Spain Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Spain Historic Review for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Spain 15-Year Perspective for Neurologic Disorders Therapeutics by Drug Class - Percentage Breakdown of Value Sales for Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes for the Years 2015, 2025 & 2030
Spain Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Spain Historic Review for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Spain 15-Year Perspective for Neurologic Disorders Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
RUSSIA
Russia Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Russia Historic Review for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Russia 15-Year Perspective for Neurologic Disorders Therapeutics by Drug Class - Percentage Breakdown of Value Sales for Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes for the Years 2015, 2025 & 2030
Russia Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Russia Historic Review for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Russia 15-Year Perspective for Neurologic Disorders Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
REST OF EUROPE
Rest of Europe Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Rest of Europe Historic Review for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Rest of Europe 15-Year Perspective for Neurologic Disorders Therapeutics by Drug Class - Percentage Breakdown of Value Sales for Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes for the Years 2015, 2025 & 2030
Rest of Europe Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Rest of Europe Historic Review for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Rest of Europe 15-Year Perspective for Neurologic Disorders Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
ASIA-PACIFIC
Neurologic Disorders Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
Asia-Pacific Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
Asia-Pacific Historic Review for Neurologic Disorders Therapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Asia-Pacific 15-Year Perspective for Neurologic Disorders Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
Asia-Pacific Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Asia-Pacific Historic Review for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Asia-Pacific 15-Year Perspective for Neurologic Disorders Therapeutics by Drug Class - Percentage Breakdown of Value Sales for Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes for the Years 2015, 2025 & 2030
Asia-Pacific Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Asia-Pacific Historic Review for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Asia-Pacific 15-Year Perspective for Neurologic Disorders Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
AUSTRALIA
Neurologic Disorders Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
Australia Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Australia Historic Review for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Australia 15-Year Perspective for Neurologic Disorders Therapeutics by Drug Class - Percentage Breakdown of Value Sales for Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes for the Years 2015, 2025 & 2030
Australia Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Australia Historic Review for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Australia 15-Year Perspective for Neurologic Disorders Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
INDIA
Neurologic Disorders Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
India Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
India Historic Review for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
India 15-Year Perspective for Neurologic Disorders Therapeutics by Drug Class - Percentage Breakdown of Value Sales for Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes for the Years 2015, 2025 & 2030
India Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
India Historic Review for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
India 15-Year Perspective for Neurologic Disorders Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
SOUTH KOREA
South Korea Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
South Korea Historic Review for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
South Korea 15-Year Perspective for Neurologic Disorders Therapeutics by Drug Class - Percentage Breakdown of Value Sales for Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes for the Years 2015, 2025 & 2030
South Korea Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
South Korea Historic Review for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
South Korea 15-Year Perspective for Neurologic Disorders Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Rest of Asia-Pacific Historic Review for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Neurologic Disorders Therapeutics by Drug Class - Percentage Breakdown of Value Sales for Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes for the Years 2015, 2025 & 2030
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Rest of Asia-Pacific Historic Review for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Neurologic Disorders Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
LATIN AMERICA
Neurologic Disorders Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
Latin America Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
Latin America Historic Review for Neurologic Disorders Therapeutics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Latin America 15-Year Perspective for Neurologic Disorders Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
Latin America Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Latin America Historic Review for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Latin America 15-Year Perspective for Neurologic Disorders Therapeutics by Drug Class - Percentage Breakdown of Value Sales for Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes for the Years 2015, 2025 & 2030
Latin America Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Latin America Historic Review for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Latin America 15-Year Perspective for Neurologic Disorders Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
ARGENTINA
Argentina Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Argentina Historic Review for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Argentina 15-Year Perspective for Neurologic Disorders Therapeutics by Drug Class - Percentage Breakdown of Value Sales for Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes for the Years 2015, 2025 & 2030
Argentina Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Argentina Historic Review for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Argentina 15-Year Perspective for Neurologic Disorders Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
BRAZIL
Brazil Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Brazil Historic Review for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Brazil 15-Year Perspective for Neurologic Disorders Therapeutics by Drug Class - Percentage Breakdown of Value Sales for Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes for the Years 2015, 2025 & 2030
Brazil Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Brazil Historic Review for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Brazil 15-Year Perspective for Neurologic Disorders Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
MEXICO
Mexico Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Mexico Historic Review for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Mexico 15-Year Perspective for Neurologic Disorders Therapeutics by Drug Class - Percentage Breakdown of Value Sales for Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes for the Years 2015, 2025 & 2030
Mexico Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Mexico Historic Review for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Mexico 15-Year Perspective for Neurologic Disorders Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
REST OF LATIN AMERICA
Rest of Latin America Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Rest of Latin America Historic Review for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Rest of Latin America 15-Year Perspective for Neurologic Disorders Therapeutics by Drug Class - Percentage Breakdown of Value Sales for Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes for the Years 2015, 2025 & 2030
Rest of Latin America Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Rest of Latin America Historic Review for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Rest of Latin America 15-Year Perspective for Neurologic Disorders Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
MIDDLE EAST
Neurologic Disorders Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
Middle East Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
Middle East Historic Review for Neurologic Disorders Therapeutics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Middle East 15-Year Perspective for Neurologic Disorders Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
Middle East Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Middle East Historic Review for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Middle East 15-Year Perspective for Neurologic Disorders Therapeutics by Drug Class - Percentage Breakdown of Value Sales for Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes for the Years 2015, 2025 & 2030
Middle East Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Middle East Historic Review for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Middle East 15-Year Perspective for Neurologic Disorders Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
IRAN
Iran Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Iran Historic Review for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Iran 15-Year Perspective for Neurologic Disorders Therapeutics by Drug Class - Percentage Breakdown of Value Sales for Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes for the Years 2015, 2025 & 2030
Iran Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Iran Historic Review for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Iran 15-Year Perspective for Neurologic Disorders Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
ISRAEL
Israel Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Israel Historic Review for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Israel 15-Year Perspective for Neurologic Disorders Therapeutics by Drug Class - Percentage Breakdown of Value Sales for Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes for the Years 2015, 2025 & 2030
Israel Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Israel Historic Review for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Israel 15-Year Perspective for Neurologic Disorders Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
SAUDI ARABIA
Saudi Arabia Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Saudi Arabia Historic Review for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Saudi Arabia 15-Year Perspective for Neurologic Disorders Therapeutics by Drug Class - Percentage Breakdown of Value Sales for Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes for the Years 2015, 2025 & 2030
Saudi Arabia Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Saudi Arabia Historic Review for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Saudi Arabia 15-Year Perspective for Neurologic Disorders Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
UNITED ARAB EMIRATES
UAE Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
UAE Historic Review for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
UAE 15-Year Perspective for Neurologic Disorders Therapeutics by Drug Class - Percentage Breakdown of Value Sales for Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes for the Years 2015, 2025 & 2030
UAE Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
UAE Historic Review for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
UAE 15-Year Perspective for Neurologic Disorders Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
REST OF MIDDLE EAST
Rest of Middle East Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Rest of Middle East Historic Review for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Rest of Middle East 15-Year Perspective for Neurologic Disorders Therapeutics by Drug Class - Percentage Breakdown of Value Sales for Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes for the Years 2015, 2025 & 2030
Rest of Middle East Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Rest of Middle East Historic Review for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Rest of Middle East 15-Year Perspective for Neurologic Disorders Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
AFRICA
Neurologic Disorders Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
Africa Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Africa Historic Review for Neurologic Disorders Therapeutics by Drug Class - Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Africa 15-Year Perspective for Neurologic Disorders Therapeutics by Drug Class - Percentage Breakdown of Value Sales for Anticholinergic Drug Class, Analgesics Drug Class, Antiepileptic Drug Class and Other Drug Classes for the Years 2015, 2025 & 2030
Africa Recent Past, Current & Future Analysis for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Africa Historic Review for Neurologic Disorders Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Africa 15-Year Perspective for Neurologic Disorders Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030

COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

%

VALIDATED RESEARCH *

* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com

[chatbot]